| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | 0.095 | 0.2 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.2 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | 0.036 | 0.2 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | GDC-0449 | FIMM | pan-cancer | AAC | -0.22 | 0.2 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | 0.064 | 0.2 |